MENU
GOSS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gossamer Bio (GOSS) Earnings Date & Reports
Gossamer Bio Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Pharmaceuticals Major
A.I. Advisor
published Earnings
GOSS is expected to report earnings to fall 38.75% to -4 cents per share on November 05
Q3'26
Est.
$-0.05
Q2'26
Beat
by $0.04
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.02
Q3'25
Missed
by $0.02
The last earnings report on August 13 showed earnings per share of -7 cents, beating the estimate of -11 cents. With 32.67M shares outstanding, the current market capitalization sits at 75.62M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology
Industry Biotechnology
Profile
Details
Industry
Pharmaceuticals Major
Address
3115 Merryfield Row
Phone
+1 858 684-1300
Employees
162
Web
https://www.gossamerbio.com